Gastric cancer (GC) is one of the most common tumors worldwide and the leading cause of
tumor-related mortality. Endoscopy and serological tumor marker testing are currently the�…

Among the various dosage forms, oral medicine has extensive benefits including ease of
administration and patients' compliance, over injectable, suppositories, ocular and nasal�…

Summary Background Expression of PD-L1 has been shown to be upregulated in some
patients with gastric cancer. As part of the phase 1b KEYNOTE-012 study, we aimed to�…

Background: The overall incidence and mortality of gastric cancer have steadily declined in
the United States over the past few decades, but it is still a serious disease burden for�…

Metaplasia is the replacement of one differentiated somatic cell type with another
differentiated somatic cell type in the same tissue. Typically, metaplasia is triggered by�…

Background Gastric cancer is the third most lethal malignancy worldwide. A novel deep
convolution neural network (DCNN) to perform visual tasks has been recently developed�…

Background Esophagogastroduodenoscopy (EGD) is a prerequisite for detecting upper
gastrointestinal lesions especially early gastric cancer (EGC). An artificial intelligence�…

The neutrophil‐lymphocyte ratio (NLR) and the platelet‐lymphocyte ratio (PLR) are markers
of systemic inflammation. However, there is little evidence of the value of inflammation in the�…

Importance The gastric cancer (GC)–associated long noncoding RNA1 (lncRNA-GC1) plays
an important role in gastric carcinogenesis. However, exosomal lncRNA-GC1 and its�…

The nuclear paraspeckle assembly transcript 1 (NEAT1) is a long non-coding RNA (lncRNA)
that is upregulated in a variety of human cancer types. Increasing evidence has shown that�…